Begin typing your search above and press return to search.
exit_to_app
Nuclear negotiations and the Israeli tactics
access_time 2021-12-08T23:15:57+05:30
The war against religious conversions
access_time 2021-12-08T11:29:01+05:30
AFSPA terrorism should end
access_time 2021-12-07T09:06:40+05:30
The President should advise - the government
access_time 2021-12-06T11:01:45+05:30
Double standards - all the way
access_time 2021-12-05T11:17:34+05:30
exit_to_app
Homechevron_rightIndiachevron_rightSC junks plea against...

SC junks plea against mass vax of Covishield, Covaxin

text_fields
bookmark_border
SC junks plea against mass vax of Covishield, Covaxin
cancel

New Delhi: The Supreme Court on Monday dismissed the challenge to the May decision of the Karnataka High Court rejecting the plea to stop Covishield and Covaxin vaccination until all the stages of the clinical trials are completed.

Refusing to interfere in the matter, a bench comprising Justices D.Y. Chandrachud and B.V. Nagarathna told the petitioner's counsel, "We do not want this matter to be argued at all. Let us not cast doubt on the vaccination".

The Counsel appearing for petitioner Mathew Thomas urged the bench to hear his arguments in the matter in detail. However, the bench responded that it was not keen on entertaining the plea.

The top court told the petitioner's counsel that it finds no error with the high court decision in the matter, and it will not entertain the petition.

The top court was hearing a plea challenging the Karnataka High Court order, which dismissed a PIL seeking directives to stop mass vaccination of Covishield and Covaxin. The court had also imposed a cost of Rs 50,000 on the petitioners for wasting precious time of the court.

In May this year, the high court, dismissing the plea, had said it was not filed in public interest and it was a fit case to impose exemplary costs as it is consumed 45 minutes, which could have been devoted to deal with important issues arising out of Covid-19.

In the high court, the petitioner's counsel had argued that it is not clear under what authority of law the Centre permitted vaccination without completing clinical trials.

Show Full Article
TAGS:supreme court Covishield Covaxin 
Next Story